Grifols, S.A.

GRFS

—

Last 30 days -5.13% May 11 → Jun 18

Open

—

High

—

Low

—

Volume

—

Avg Vol

—

Mkt Cap

$5.1B

P/E (TTM)

—

Beta

—

52w High

—

52w Low

—

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 5 items

Jun 19 · 16:52 Insider Monkey

Grifols (GRFS) Launches FESILTY in the U.S. for Congenital Fibrinogen Deficiency Treatment

Jun 15 · 12:33 MT Newswires

Grifols Launches Fesilty Blood Clotting Concentrate in US

Jun 15 · 12:00 PR GlobeNewswire

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

▸ Show all 5 press releases & news Free account →

Overview

52-week range

—

Avg surprise (last 1)

-17.4%

Avg reaction (last 0)

—

Earnings trends

EPS — actual vs estimate Actual Estimate

Earnings history

Date	Period	Actual EPS	Est	Surprise	YoY %Δ	Day react	Source
Mon Jul 28, 2025	Jun/2025	$0.19	$0.23	-17.4%	—	—	earnings

Implied volatility — last 90 days

No IV snapshots yet for GRFS.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

View on Nasdaq ↗